Yong Zou

4.4k total citations
48 papers, 1.2k citations indexed

About

Yong Zou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yong Zou has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 18 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Yong Zou's work include RNA modifications and cancer (14 papers), Epigenetics and DNA Methylation (10 papers) and MicroRNA in disease regulation (5 papers). Yong Zou is often cited by papers focused on RNA modifications and cancer (14 papers), Epigenetics and DNA Methylation (10 papers) and MicroRNA in disease regulation (5 papers). Yong Zou collaborates with scholars based in China, United States and United Kingdom. Yong Zou's co-authors include Pierre P. Massion, Yiqun Huang, Megan D. Hoeksema, S.M. Jamshedur Rahman, Rosana Eisenberg, Jun Qian, Bradford K. Harris, Xudong Ma, Xiangming Ji and Heidi Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yong Zou

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Zou China 20 810 390 284 218 122 48 1.2k
Limei Xu China 14 805 1.0× 303 0.8× 253 0.9× 148 0.7× 87 0.7× 24 1.1k
Paula Sotomayor United States 22 658 0.8× 246 0.6× 307 1.1× 298 1.4× 139 1.1× 32 1.3k
Sun Young Yoon South Korea 18 816 1.0× 295 0.8× 162 0.6× 319 1.5× 154 1.3× 56 1.3k
Funeng Jiang China 25 954 1.2× 564 1.4× 330 1.2× 280 1.3× 115 0.9× 65 1.5k
Subbulakshmi Virudachalam United States 18 705 0.9× 274 0.7× 160 0.6× 381 1.7× 98 0.8× 21 1.2k
Shuang Shang China 15 1.0k 1.3× 299 0.8× 235 0.8× 357 1.6× 205 1.7× 23 1.6k
Li Su Taiwan 24 1.1k 1.4× 358 0.9× 264 0.9× 388 1.8× 98 0.8× 66 1.7k
Jie Lin China 21 749 0.9× 473 1.2× 169 0.6× 185 0.8× 75 0.6× 55 1.0k
Kai‐Wen Hsu Taiwan 23 1.1k 1.4× 533 1.4× 109 0.4× 280 1.3× 94 0.8× 49 1.5k

Countries citing papers authored by Yong Zou

Since Specialization
Citations

This map shows the geographic impact of Yong Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Zou more than expected).

Fields of papers citing papers by Yong Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Zou. The network helps show where Yong Zou may publish in the future.

Co-authorship network of co-authors of Yong Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Zou. A scholar is included among the top collaborators of Yong Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Zou. Yong Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arimura, Ken, Michael N. Kammer, Saifur Rahman, et al.. (2024). Elucidating the role of EPPK1 in lung adenocarcinoma development. BMC Cancer. 24(1). 441–441. 1 indexed citations
2.
Huang, Yi‐You, Xiang Luo, Kai Zhang, et al.. (2024). Structure-based optimization of isoaurostatin as novel PDE4 inhibitors with anti-fibrotic effects. Chinese Chemical Letters. 36(8). 110586–110586. 1 indexed citations
3.
Sinha, Abhilasha, Yong Zou, Ayushi S. Patel, et al.. (2022). Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy. Cancers. 14(3). 708–708. 12 indexed citations
4.
Li, Shuying, Yan Yin, Dan Xiao, & Yong Zou. (2021). Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients. BMC Gastroenterology. 21(1). 314–314. 13 indexed citations
5.
Li, Xiujuan, Jing Liu, Hong Sun, et al.. (2020). SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer. Acta Biochimica Polonica. 67(2). 165–172. 14 indexed citations
6.
Qian, Jun, Shilin Zhao, Yong Zou, et al.. (2019). Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 201(6). 697–706. 37 indexed citations
7.
Li, Juan, Tianxu Liu, Guojun Jiang, et al.. (2019). Suppression of inflammation by ethanol extract of Clausena lansium via modulation of TLR4/MYD88/TRAF6 signaling pathway in RAW 264.7 macrophages. SHILAP Revista de lepidopterología. 17. 3 indexed citations
8.
Lin, Wanfu, Zifei Yin, Yong Zou, et al.. (2019). Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 28 indexed citations
9.
Meyer, Anne R., Amy C. Engevik, Spencer G. Willet, et al.. (2019). Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury. Cellular and Molecular Gastroenterology and Hepatology. 8(3). 379–405. 30 indexed citations
10.
Liang, Shufang, Yong Zou, Xiaolin Liu, et al.. (2018). The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways. Evidence-based Complementary and Alternative Medicine. 2018(1). 5629304–5629304. 13 indexed citations
11.
12.
Huang, Yiqun, et al.. (2017). Synergistic effects of phenylhexyl isothiocyanate and LY294002 on the PI3K/Akt signaling pathway in HL-60 cells. Oncology Letters. 14(3). 3043–3050. 4 indexed citations
13.
Rahman, S.M. Jamshedur, Xiangming Ji, Lisa J. Zimmerman, et al.. (2016). The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight. 1(19). e88814–e88814. 28 indexed citations
14.
Lin, Xiaolei, et al.. (2016). Depletion of G9a gene induces cell apoptosis in human gastric carcinoma. Oncology Reports. 35(5). 3041–3049. 21 indexed citations
15.
Cai, Li‐Sheng, et al.. (2014). Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Oncology Reports. 31(6). 2593–2600. 28 indexed citations
16.
Wang, Jing, Jun Qian, Megan D. Hoeksema, et al.. (2013). Integrative Genomics Analysis Identifies Candidate Drivers at 3q26-29 Amplicon in Squamous Cell Carcinoma of the Lung. Clinical Cancer Research. 19(20). 5580–5590. 53 indexed citations
17.
Ocak, Sebahat, Hironobu Yamashita, Akshata R. Udyavar, et al.. (2010). DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene. 29(48). 6331–6342. 36 indexed citations
18.
Massion, Pierre P., Yong Zou, Holly J. Wolf, et al.. (2009). Recurrent Genomic Gains in Preinvasive Lesions as a Biomarker of Risk for Lung Cancer. PLoS ONE. 4(6). e5611–e5611. 37 indexed citations
19.
Qian, Jun, et al.. (2009). Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Molecular Cancer Therapeutics. 8(1). 101–109. 64 indexed citations
20.
Massion, Pierre P., Yong Zou, Heidi Chen, et al.. (2008). Smoking-related Genomic Signatures in Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 178(11). 1164–1172. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Limei Xu Breakdown of academic impact, for papers by Paula Sotomayor Breakdown of academic impact, for papers by Sun Young Yoon Breakdown of academic impact, for papers by Funeng Jiang Breakdown of academic impact, for papers by Subbulakshmi Virudachalam Breakdown of academic impact, for papers by Shuang Shang Breakdown of academic impact, for papers by Li Su Breakdown of academic impact, for papers by Jie Lin Breakdown of academic impact, for papers by Kai‐Wen Hsu
Rankless by CCL
2026